Study of Silymarin for Improving Hepatitis C
Study of Silymarin for Improving Hepatitis C
The purpose of this study is to determine the effects of silymarin on outcomes of patients with hepatitis C.
Silymarin has been claimed to have a beneficial effect in various types of liver injury, including alcoholic liver disease, drug and toxin induced hepatotoxicity, and acute and chronic viral hepatitis.
Inclusion Criteria:
confirmed chronic hepatitis C (HCV Ab (+), HCV RNA (with PCR) (+)) normal or increased liver enzymes (ALT and AST) not using interferon or ribavirin due to patient sensitivity or not consenting.
Exclusion Criteria:
The pregnant patients patients with side effect which confirmed with rechallenge test